信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·1500元/瓶！又一进口新冠药今起上市销售，可报销！这家公司是唯一经销商2023-1-13 9:18:25
·1500元/瓶！又一进口新冠药今起上市销售可报销！这家公司是唯一经销商2023-1-13 8:59:29
·国产新冠“特效药”的生死竞速2023-1-13 7:45:39
·股票行情快报：仙琚制药（002332）1月12日主力资金净买入4213.98万元2023-1-12 22:17:38
·上交所：新通药物科创板首发过会2023-1-12 21:34:56
·科创板上市委：新通药物首发获通过 泰凌微暂缓审议2023-1-12 21:18:01
·国产乙肝靶向创新药研发领军企业 新通药物科创板IPO顺利过会2023-1-12 21:13:56
·默沙东新冠口服药莫诺拉韦明天上市销售配药需通过医疗机构2023-1-12 20:19:07
·互动|西藏药业：公司产品诺迪康能够促进血氧提升和恢复血氧2023-1-12 17:58:48
·新华制药：OAB-14干混悬剂获药物临床试验批准通知书2023-1-12 17:28:33
·易明医药（002826）1月12日主力资金净卖出456.64万元2023-1-12 16:15:52
·这款国产口服药转阴比辉瑞P药快？2023-1-12 15:43:17
·誉衡药业子公司减值致亏损2.7-3.1亿并购“后遗症”未消除经营能力遭质疑2023-1-12 12:42:05
·誉衡药业（002437）1月11日主力资金净卖出2757.08万元2023-1-12 10:58:46
·誉衡药业并购后遗症净利最高预亏3.1亿朱吉满逾7亿股将被拍卖或失控制权2023-1-12 10:58:32
·专注创新药自主研发 必贝特科创板IPO过会2023-1-12 10:23:56
·又一新冠药来袭首发报价1500元！国内生产商也确认2023-1-12 10:11:13
·新通药物再闯科创板多处信息披露自相矛盾2023-1-12 10:09:05
·弘森药业向江苏证监局报送了向不特定合格投资者公开发行股票并在北京证券交易所上市辅导备案材料2023-1-11 23:43:32
·创新性曾遭问询 新通药物科创板IPO二度上会2023-1-11 23:29:04

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]